SAVA 241122 30.50P (SAVA241122P30500) Stock Options, News & Quotes

US OptionsDetailed Quotes

SAVA241122P30500

Watchlist

4.00
+2.25+128.57%

15min DelayClose Nov 22 16:00 ET

4.00High1.80Low

Intraday

5D
Daily

News

Express News | Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
ReutersNov 18 08:30 ET
Press Release: Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
Dow JonesNov 18 08:30 ET
Cassava Sciences Updates on Phase 3 Alzheimer's Trial Ahead of Key Readout
Seeking AlphaNov 15 11:17 ET
Cassava Sciences' Simufilam 100 Mg For Mild-To-Moderate Alzheimer's Disease (RETHINK-ALZ) Posted On ClinicalTrials Website On November 15, 2024
BenzingaNov 15 10:51 ET
Cassava Sciences Analyst Ratings
BenzingaNov 8 14:27 ET · Ratings
H.C. Wainwright Maintains Cassava Sciences(SAVA.US) With Buy Rating, Maintains Target Price $116
Moomoo NewsNov 8 07:35 ET · Ratings

Comments

JAYYFLASH

2 hours ago

$Cassava Sciences (SAVA.US)$ Someone Loaded Up Buying 81k shares for $2 Million .🔥 They have been shorting to buy lots of shares at lower price to position themselves better before the soon data readout.

Eric Soucy

3 hours ago

$Cassava Sciences (SAVA.US)$ Crazy how this company's getting manipulated, one day you hear people are buying like crazy and next its down 20% 🤣🤣

JAYYFLASH

4 hours ago

$Cassava Sciences (SAVA.US)$ Last Night, We Witnessed SAVA 24 Hour Market trading and it was only Available on Robinhood but no other trading platforms. Is this a way for shorts to be able to cover their short position at any time that the trial results come out? With All the Naked shorting and SEC clearly being worthless and helping market manipulators with no accountability of complaints, The Shares Short amount is definitely much higher than 45%. The market unfairness of having longs wait for ...

JAYYFLASH

20 hours ago

$Cassava Sciences (SAVA.US)$SAVA still trading up now past after hours

JAYYFLASH

Yesterday 07:10

$Cassava Sciences (SAVA.US)$ New Form 4 by Clinical Dev Officer. All the way Bullish